Nitrate is the active ingredient. specific formulations may include additional excipients like preservatives, emulsifiers, and bases depending on the product type (e.g., cream, ointment).
Treatment of superficial fungal infections of the skin (e.g., tinea pedis, tinea cruris, tinea corporis, candidiasis).
Treatment of cutaneous candidiasis.
Ebernet Lotion 40gm (Eberconazole) is an imidazole antifungal agent. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. This disruption leads to increased membrane permeability, ultimately causing fungal cell death.
Store at room temperature (below 25°C). Protect from light and moisture. Keep out of reach of children. Discard any unused portion after the expiry date.
Apply a thin layer of the medication to the affected area twice daily, or as directed by a physician.
Dosage and duration of treatment depend on the severity and location of the infection. Always follow the prescribed regimen.
Local skin irritation (burning, itching, redness).
Rare cases of allergic contact dermatitis.
No known specific interaction with alcohol, but excessive alcohol consumption can impair immune function and healing.
Generally safe, but avoid if experiencing side effects like dizziness or drowsiness (although this is rare with topical application).
Consult a healthcare professional before use during pregnancy or breastfeeding. Topical application has a low risk of systemic absorption, but caution is advised.
Use only as directed by a physician. Dosage and application may need to be adjusted depending on age and body surface area.
No specific precaution needed for those with kidney disease as systemic absorption from topical use is low.
No specific precaution needed for those with liver disease as systemic absorption from topical use is low.
Please consult your physician or pharmacist for detailed information. This information is for general knowledge and does not substitute professional medical advice.
List relevant medical databases/journals if available for the specific eberconazole formulation being discussed.
